Pharmaceuticals

Innovative Biomarker Testing Driving Growth in the Biomarkers Market

March 18, 2026March 18, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Biomarkers Market Over The 2026–2030 Period?

The biomarkers market has experienced substantial expansion in recent years. Its size is projected to increase from $77.42 billion in 2025 to $88.42 billion by 2026, achieving a compound annual growth rate (CAGR) of 14.2%. This historical growth can be ascribed to advancements in molecular biology, increased spending on pharmaceutical research and development, the rising prevalence of cancer, broader adoption in clinical trials, and the demand for targeted therapies.

The biomarkers market is anticipated to experience substantial expansion over the coming years. This market is projected to reach $150.52 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.2%. The drivers behind this projected growth include the broadening of personalized treatment methods, the increasing uptake of liquid biopsy biomarkers, augmented regulatory backing for biomarker-driven pharmaceuticals, advancements in neurological disease studies, and growing partnerships among pharmaceutical and diagnostic companies. Key trends during this period are expected to encompass the wider application of biomarkers in precision medicine, their enhanced integration into drug discovery and development processes, their increased use in managing oncology and chronic conditions, the proliferation of companion diagnostics, and a sharpened emphasis on detecting diseases at earlier stages.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6485&type=smp

What Underlying Factors Are Accelerating The Growth Of The Biomarkers Market?

The rising incidence of heart diseases is anticipated to propel the growth of the biomarkers market in the forecasted period. The application of biomarkers for patients suffering from heart conditions has witnessed a substantial increase over the past few years. Currently, natriuretic peptides are the most widely used biomarker, assisting in the diagnosis of individuals with heart failure. Biomarkers such as circulating biomarkers with high sensitivity C-reactive protein are employed for diagnosing heart failure. Heart disease stands as a leading cause of death for people across most racial and ethnic groups in the United States. This rise in heart diseases will consequently drive the demand for biomarkers. For instance, in September 2025, according to the British Heart Foundation, a UK-based charity, more than 7.6 million people, including over 4 million men and more than 3.6 million women, are living with cardiovascular disease throughout the UK. Projections further indicate that, influenced by an aging population and improved survival rates, the number of affected individuals could increase by approximately 1 million by 2030 and by around 2 million by 2040. Therefore, the increase in heart diseases is significantly fostering the expansion of the biomarkers market.

How Is The Biomarkers Market Segmented Across Key Categories?

The biomarkers market covered in this report is segmented –

1) By Technology: Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers

2) By Disease: Neurological Diseases, Cancer, Immunological Diseases, Cardiovascular Diseases, Other Diseases

3) By Type: Biomarker Of Exposure, Biomarker Of Diseases

4) By Audiences: Pharmaceutical Companies, Government And Private Research Institutes, Academic Institutes, Medical Device Manufacturing Companies

Subsegments:

1) By Safety Biomarkers: Toxicity Biomarkers, Pharmacokinetic Biomarkers, Adverse Effect Biomarkers

2) By Efficacy Biomarkers: Pharmacodynamic Biomarkers, Disease Progression Biomarkers, Treatment Response Biomarkers

3) By Validation Biomarkers: Analytical Validation Biomarkers, Clinical Validation Biomarkers, Qualification Biomarkers

Which Upcoming Trends Are Expected To Influence The Biomarkers Market?

Leading companies active in the biomarker market are developing innovative offerings such as biomarker tests to serve broader customer bases, achieve more sales, and increase revenue. Biomarker tests, also known as biomarker assays, are laboratory or diagnostic techniques that quantify specific biological markers, which may encompass molecules, genes, proteins, or other substances, to yield information regarding various physiological or pathological processes within the body. For example, in July 2023, Quest Diagnostics, a US-based medical laboratories company, unveiled a new prostate cancer biomarker test. The recently introduced tissue-based test service aims to fulfill the pressing clinical requirement for tests that can aid in identifying potentially aggressive cases of prostate cancer in males. Quest developed and validated this laboratory test through an intellectual property license agreement with Envision, permitting the application of Envision’s exclusive biomarker and immunohistochemistry technology, which integrates Envision’s distinct staining approaches and pioneering biomarkers referred to as EV1, EV2, and EV3.

Who Are The Dominant Players Shaping The Biomarkers Market Landscape?

Major companies operating in the biomarkers market are Enzo Biochem Inc, Bio-Rad Laboratories Inc., Merck KGaA, PerkinElmer Inc., QIAGEN N. V., Adaptive Biotechnologies Corp., Agilent Technologies Inc., Biocrates Life Sciences AG, BioFire Diagnostics LLC, BioReference Laboratories Inc., Bio-Techne Corporation, Cepheid Inc., Eurofins Scientific SE, Exact Sciences Corporation, Foundation Medicine Inc., Genomic Health Inc., GenScript Biotech Corporation, Guardant Health Inc., Illumina Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Luminex Corporation, Metabolon Inc., Myriad Genetics Inc., Natera Inc., Pacific Biosciences of California Inc., Quest Diagnostics Incorporated, Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Veracyte Inc.

Read the full biomarkers market report here:

https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report

Which Region Is Projected To Dominate The Biomarkers Market During The Forecast Period?

North America was the largest region in the biomarkers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarkers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Biomarkers Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=6485&type=smp

Browse Through More Reports Similar to the Global Biomarkers Market 2026, By The Business Research Company

Biomarkers Market Report 2026

https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report

Clinical Biomarkers Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-biomarkers-global-market-report

Cancer Biomarker Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-biomarker-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795